Search clinical trials for: Biphasic Insulin Aspart

Total 8282 results

Novo Nordisk A/S

Completed

Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice

Diabetes Mellitus, Type 2 | Diabetes

Indonesia
Novo Nordisk A/S

Completed

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes (BOOST™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Poland, Puerto Rico, Spain, Russian Federation, Turkey, Austria, India, Korea, Republic of
Novo Nordisk A/S

Completed

Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689

Diabetes | Diabetes Mellitus, Type 1

France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Czech Republic, Poland
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACCORD)

Cardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | Hypercholesterolemia

United States, Canada
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany
Novo Nordisk A/S

Completed

Surveillance Study of NovoRapid® for New Drug Re-examination

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Korea, Republic of
Novo Nordisk A/S

Completed

Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Philippines
Novo Nordisk A/S

Completed

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Diabetes Mellitus, Type 2 | Diabetes | Delivery Systems

United States
Novo Nordisk A/S

Completed

Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)

Healthy | Diabetes

Denmark
Novo Nordisk A/S

Completed

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Delivery Systems

Denmark
Novo Nordisk A/S

Completed

Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

Diabetes | Diabetes Mellitus, Type 1

Romania
University of Florida
Novo Nordisk A/S; VA Office of Research and Development

Completed

Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes

Type 2 Diabetes

United States
Dr. Muhammad Abdulghani

Unknown

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Type 2 Diabetes

Qatar
Yale University

Completed

Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs (PK/PD)

Diabetes Mellitus, Type I
Florida Atlantic University
Advanced Diabetes Treatment Centers

Withdrawn

Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes

Diabetes Mellitus, With Complications

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers; Global Infusions

Withdrawn

Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness

Hypoglycemia

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers

Terminated

Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus

Diabetes Mellitus, With Complications

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers; Global Infusions

Withdrawn

Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes

Diabetic Neuropathy

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers

Terminated

Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes

Diabetes Mellitus

United States
Kinderkrankenhaus auf der Bult
Hannover Medical School

Withdrawn

How to be Safe With Alcoholic Drinks in Diabetes (BEER)

Hypoglycemia | Type 1 Diabetes Mellitus

Germany
Julphar Gulf Pharmaceutical Industries
Profil Institut für Stoffwechselforschung GmbH

Completed

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III

Diabetes Mellitus

Germany
Medical University of Warsaw

Unknown

Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.

Diabetes type1

Poland
Region Örebro County
Uppsala-Örebro Regional Research Council

Completed

Treatment of Impaired Glucose Tolerance in Pregnancy (TIP)

Impaired Glucose Tolerance | Fetal Macrosomia

Sweden
University Hospital, Brest

Completed

Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump (BOLUS)

Diabetes Type 1

France
Swiss Federal Institute of Technology
PATH

Completed

The Effect of Zinc on Iron Bioavailability From Fortified Extruded Rice Fortified With Ferric Pyrophosphate (Rice_FeZn)

Iron Deficiency

Switzerland
Novo Nordisk A/S

Completed

Special Survey for Patients With Type 1 or Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Japan
Novo Nordisk A/S

Completed

Paediatric Subjects - Special Survey

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Japan
Novo Nordisk A/S

Completed

Special Survey for Type 1 or Type 2 Diabetic Patients

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Japan
Novo Nordisk A/S

Completed

Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Special Survey of Production of Insulin Aspart Specific Antibody

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Japan
Novo Nordisk A/S

Completed

Special Survey for Paediatric Subjects

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Japan
CPEX Pharmaceuticals Inc.

Withdrawn

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

Type 1 Diabetes Mellitus
Florida Atlantic University
Advanced Diabetes Treatment Centers

Terminated

Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes

Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

Healthy | Diabetes

Germany
Vancouver General Hospital

Terminated

Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia (PTHG)

Post-Transplant Glucocorticoid Induced Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Radboud University Medical Center

Completed

Reliability of Insulin by Jet Injection

Diabetes Mellitus

Netherlands
Postgraduate Institute of Medical Education and...

Completed

Comparison of Thrice Daily Biphasic Human Insulin With Basal Bolus Regimen in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

India
Novo Nordisk A/S

Completed

Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

Healthy | Diabetes

Japan
Novo Nordisk A/S

Completed

A Comparison Between Two Formulations of NN5401 in Healthy Subjects

Healthy | Diabetes

United States
Jeff Burns, MD

Completed

Memory and Insulin in Early Alzheimer's Disease (MAIN)

Alzheimer's Disease

United States
M.D. Anderson Cancer Center
Novo Nordisk A/S

Terminated

Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

Lymphoma | Leukemia

United States
Imperial College London
University of London; Royal College of Physicians; Paddington Charitable Estates...

Completed

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Hepatic Encephalopathy | Cirrhosis

United Kingdom
Novo Nordisk A/S

Completed

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

South Africa, United Arab Emirates, India
AstraZeneca

Completed

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects

Healthy | Diabetes

Germany
University of Pennsylvania

Withdrawn

Pilot Study of Clinician-supported Patient Self-management of Hospital Insulin Therapy

Diabetes Mellitus

United States

Search clinical trials for: Biphasic Insulin Aspart

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations